{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:22:47Z","timestamp":1789676567644,"version":"4.0.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12098-019-02902-x","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T03:18:48Z","timestamp":1551669528000},"page":"551-554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic Significance of IL-6 in Hodgkin Lymphoma"],"prefix":"10.1007","volume":"86","author":[{"given":"Sainath","family":"Bhethanabhotla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreenivas","family":"Vishnubhatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Bakhshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"2902_CR1","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1200\/JCO.2014.59.4853","volume":"33","author":"C Mauz-K\u00f6rholz","year":"2015","unstructured":"Mauz-K\u00f6rholz C, Metzger ML, Kelly KM, et al. Pediatric hodgkin lymphoma. J Clin Oncol. 2015;33:2975\u201385.","journal-title":"J Clin Oncol"},{"key":"2902_CR2","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1182\/blood-2003-08-2860","volume":"103","author":"W Cozen","year":"2004","unstructured":"Cozen W, Gill PS, Ingles SA, et al. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood. 2004;103:3216\u201321.","journal-title":"Blood"},{"key":"2902_CR3","doi-asserted-by":"publisher","first-page":"6812","DOI":"10.1158\/1078-0432.CCR-13-1879","volume":"19","author":"PR Marri","year":"2013","unstructured":"Marri PR, Hodge LS, Maurer MJ, et al. Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma. Clin Cancer Res. 2013;19:6812\u20139.","journal-title":"Clin Cancer Res"},{"key":"2902_CR4","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1200\/JCO.2006.08.1331","volume":"25","author":"R-O Casasnovas","year":"2007","unstructured":"Casasnovas R-O, Mounier N, Brice P, et al. Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin\u2019s lymphoma: a study from the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte. J Clin Oncol. 2007;25:1732\u201340.","journal-title":"J Clin Oncol"},{"key":"2902_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-2141.2002.03575.x","volume":"118","author":"GM Reynolds","year":"2002","unstructured":"Reynolds GM, Billingham LJ, Gray LJ, et al. Interleukin 6 expression by Hodgkin\/reed-Sternberg cells is associated with the presence of \u201cB\u201d symptoms and failure to achieve complete remission in patients with advanced Hodgkin\u2019s disease. Br J Haematol. 2002;118:195\u2013201.","journal-title":"Br J Haematol"},{"key":"2902_CR6","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1080\/10428194.2016.1262951","volume":"58","author":"S Bhethanabhotla","year":"2017","unstructured":"Bhethanabhotla S, Jain S, Kapoor G, et al. Outcome of pediatric advanced Hodgkin lymphoma treated with ABVD and predictors of inferior survival: a multicenter study of 186 patients. Leuk Lymphoma. 2017;58:1617\u201323.","journal-title":"Leuk Lymphoma"},{"key":"2902_CR7","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1200\/JCO.1990.8.9.1598","volume":"8","author":"CL Olweny","year":"1990","unstructured":"Olweny CL. Cotswolds modification of the Ann Arbor staging system for Hodgkin\u2019s disease. J Clin Oncol. 1990;8:1598.","journal-title":"J Clin Oncol"},{"key":"2902_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0959-8049(94)90249-6","volume":"30A","author":"JY Blay","year":"1994","unstructured":"Blay JY, Farcet JP, Lavaud A, Radoux D, Choua\u00efb S. Serum concentrations of cytokines in patients with Hodgkin\u2019s disease. Eur J Cancer. 1994;30A:321\u20134.","journal-title":"Eur J Cancer"},{"key":"2902_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0002-9343(96)00352-X","volume":"102","author":"JF Seymour","year":"1997","unstructured":"Seymour JF, Talpaz M, Hagemeister FB, Cabanillas F, Kurzrock R. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin\u2019s disease. Am J Med. 1997;102:21\u20138.","journal-title":"Am J Med"},{"key":"2902_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/oxfordjournals.annonc.a059218","volume":"6","author":"M Gorschl\u00fcter","year":"1995","unstructured":"Gorschl\u00fcter M, Bohlen H, Hasenclever D, Diehl V, Tesch H. Serum cytokine levels correlate with clinical parameters in Hodgkin\u2019s disease. Ann Oncol. 1995;6:477\u201382.","journal-title":"Ann Oncol"},{"key":"2902_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235\u20138.","journal-title":"Nature"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-019-02902-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-019-02902-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-019-02902-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T19:21:35Z","timestamp":1583176895000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-019-02902-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["2902"],"URL":"https:\/\/doi.org\/10.1007\/s12098-019-02902-x","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"14 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}